| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 71.745 | 184.653 | 378.411 | 521.623 | 705.377 | 794.064 | 707.416 |
| Total Income - EUR | - | - | 0 | 71.745 | 196.530 | 378.816 | 523.647 | 706.292 | 794.065 | 710.213 |
| Total Expenses - EUR | - | - | 0 | 45.311 | 163.339 | 203.626 | 258.504 | 404.154 | 493.110 | 579.254 |
| Gross Profit/Loss - EUR | - | - | 0 | 26.434 | 33.191 | 175.190 | 265.142 | 302.137 | 300.955 | 130.960 |
| Net Profit/Loss - EUR | - | - | 0 | 25.698 | 31.251 | 171.393 | 259.905 | 297.112 | 275.875 | 110.317 |
| Employees | - | - | 0 | 14 | 16 | 28 | 30 | 23 | 27 | 26 |
Check the financial reports for the company - Investigaţii Alexmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 20.783 | 67.849 | 61.291 | 184.906 | 198.376 | 190.081 | 191.379 |
| Current Assets | - | - | 66 | 36.803 | 68.535 | 239.551 | 231.974 | 297.147 | 323.749 | 112.186 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 88 | 2.126 | 487 |
| Receivables | - | - | 0 | 26.510 | 64.725 | 53.833 | 164.547 | 260.580 | 194.751 | 104.134 |
| Cash | - | - | 66 | 10.293 | 3.810 | 185.718 | 67.427 | 36.479 | 126.872 | 7.565 |
| Shareholders Funds | - | - | 66 | 25.762 | 56.514 | 226.836 | 260.026 | 294.032 | 275.996 | 110.437 |
| Social Capital | - | - | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | 0 | 31.824 | 86.083 | 74.007 | 156.854 | 201.491 | 237.834 | 193.128 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Investigaţii Alexmed S.r.l.